Genmab A (GMAB) Interest Coverage Ratio Growth (1y) (2025 - 2026)

Genmab A (GMAB) Interest Coverage Ratio Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Oculis Holding AG 66,140.12 Bn 66,139.83 Bn - -60.44%
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn - -347.04%
4 BeOne Medicines 472.04 Bn 467.25 Bn 1.35 Bn 787.12%
5 Vertex Pharmaceuticals 122.28 Bn 115.03 Bn 2.59 Bn 53.59%
6 Regeneron Pharmaceuticals 70.07 Bn 61.31 Bn 3.31 Bn -32.04%
7 Belite Bio 62.66 Bn 62.66 Bn - -
8 Argenx Se 56.16 Bn 50.98 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.56 Bn 34.55 Bn 959.66 Mn 1,378.45%
10 Genmab A 1.87 Bn 353.33 Mn 831.00 Mn 71.28%

Historic Data

Download Data
DateValue
Mar 31, 2026 71.28%
Sep 30, 2025 -61.96%
Jun 30, 2025 7.06%
Mar 31, 2025 -26.05%